question: Compared to treatment as usual (TAU) what was the result of open-label placebo (OLP) on fatigue-disrupted quality of life?
context:  and a 39% improvement in fatigue-disrupted quality of life (MD = 11.76, 95% CI 4.65, 18.86; P = 0.002), a large effect (d = 0.76)